Effect of furosemide and furosemide–carbazochrome combination on exercise-induced pulmonary hemorrhage in Standardbred racehorses

The objective was to quantify the effect of furosemide and carbazochrome on exercise-induced pulmonary hemorrhage (EIPH) in Standardbred horses using red blood cell count and hemoglobin concentration in bronchoalveolar lavage (BAL) fluid. Six healthy Standardbred horses with prior evidence of EIPH performed a standardized treadmill test 4 h after administration of placebo, furosemide, or furosemide–carbazochrome combination. Red blood cell (RBC) counts and hemoglobin concentrations were determined on the BAL fluid. The RBC count in BAL ranges were (2903–26 025 cells/μL), (45–24 060 cells/μL), and (905–3045 cells/μL) for placebo, furosemide, and furosemide–carbazochrome, respectively. Hemoglobin concentration ranges were (0.03–0.59 mg/mL), (0.01–0.55 mg/mL), and (0.007–0.16 mg/mL) for placebo, furosemide, and furosemide– carbazochrome groups, respectively. No significant differences were detected among treatments. However, there was great variability among horses, suggesting that a larger sample size or better selection of horses was needed.